Alaunos Therapeutics | ZIOP - Capital Ordinaire





Capital Ordinaire Changement Date
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 541M 1000K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Baxter International USD 517M 549K 2026-06
Biogen USD 146.7M 200K 2025-09
Bioline Rx USD 2.61B 0 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celltrion KRW 229.65M 11.03M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Curis USD 2M 10.93M 2026-03
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Divis Laboratories Ltd INR 265.47M 0 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
J&J USD 2.41B 1.35M 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Merck USD 2.47B 4.93M 2026-03
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Novartis USD 1.9B 7.38M 2026-06
Organigram Holdings CAD 136.47M 1.34M 2026-03
Ovoca Bio EUR 29.49M 0 2025-12
Pfizer USD 5.7B 0 2026-06
Pharma Mar EUR 17.34M 24.24K 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Qiagen NV USD 206.5M 245K 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sartorius EUR 69.05M 0 2026-06
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Tilray USD 116.52M 5.01M 2025-09
Verastem USD 87.84M 10.1M 2026-03
Zealand Pharma A/S 70.66M 53K 2026-03
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03